{
  "id": 6886216,
  "title": "Study Finds New Eye Drops to Improve Night Vision",
  "url": "https://urgent.news/2026/09/12/study-finds-new-eye-drops-to-improve-night-vision",
  "topic": "science",
  "section": "Science",
  "published": "2026-09-12T07:26:13.000Z",
  "source": {
    "name": "ProPakistani",
    "slug": "propakistani",
    "url": "https://propakistani.pk/2026/09/12/study-finds-new-eye-drops-to-improve-night-vision/"
  },
  "original_language": "en",
  "account": "A new treatment for poor night vision, developed by Opus Genetics, has shown promising results in two late-stage studies. In the first trial, 145 patients with vision issues in low-light conditions and symptoms like glare, halos, and starbursts were tested. These patients received either a 0.75% phentolamine ophthalmic solution or a placebo for either eight or 15 days. After just eight days, 13% of the treatment group showed improvement, compared to only 3% of the placebo group. By day 15, this improvement rate increased to 21% among those using the eye drops, while the placebo group remained at 3%.\n\nThe eye drops were found to work by targeting a muscle in the iris, causing moderate pupil constriction for up to 20 hours. This could potentially help improve night vision, especially for those who have experienced vision problems after procedures like LASIK surgery. In the second Phase III trial, researchers reported early promising results, noting that patients experienced better visibility under oncoming headlights and improved vision during dawn or dusk glare. The US Food and Drug Administration has granted Fast Track designation to these eye drops, which could expedite the approval process.",
  "summary": "Eye drops developed by Opus Genetics have significantly improved night vision in people who struggle to drive in the dark, … Read More The post Study Finds New Eye Drops to Improve Night Vision appeared first on ProPakistani .",
  "key_points": [
    "Opus Genetics developed eye drops for night vision improvement.",
    "145 patients in trials showed 13% improvement in 8 days.",
    "FDA granted Fast Track designation to expedite approval."
  ],
  "editors_take": "The new eye drops' promising results signal a potential shift in treatment options for people struggling with night vision, particularly those with post-surgical complications like LASIK-related vision problems.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}